Prot #NU 19S01: A Phase II Study of Cabozantinib and Temozolomide in Patients with Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas

Project: Research project

Project Details

StatusActive
Effective start/end date11/25/1911/25/24

Funding

  • Exelixis Inc. (Prot #NU 19S01)